T Caulfield

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. ncbi The stem cell research environment: a patchwork of patchworks
    Timothy Caulfield
    Health Law Institute, Faculty of Law, University of Alberta, Edmonton, Canada
    Stem Cell Rev 5:82-8. 2009
  2. ncbi DTC genetic testing: pendulum swings and policy paradoxes
    T Caulfield
    Health Law and Science Policy Group, University of Alberta, Edmonton, AB T6G 2H5, Canada
    Clin Genet 81:4-6. 2012
  3. ncbi The evolution of policy issues in stem cell research: an international survey
    Timothy Caulfield
    Health Law and Science Policy Group, University of Alberta, Edmonton, AB, Canada
    Stem Cell Rev 8:1037-42. 2012
  4. ncbi Science and the sources of hype
    T Caulfield
    Law Centre, University of Alberta, Edmonton, AB, Canada
    Public Health Genomics 15:209-17. 2012
  5. ncbi Open science versus commercialization: a modern research conflict?
    Timothy Caulfield
    Health Law and Science Policy Group, Law Centre, University of Alberta, Edmonton, T6G 2H5, Canada
    Genome Med 4:17. 2012
  6. ncbi Race and ancestry in biomedical research: exploring the challenges
    Timothy Caulfield
    Faculty of Law and School of Public Health Research, Health Law Institute, University of Alberta, 89 Ave and 111 St, T6G 2H5, Canada
    Genome Med 1:8. 2009
  7. ncbi Commercialization, patenting and genomics: researcher perspectives
    Cj Murdoch
    Health Law Institute, Law Centre, University of Alberta, 89th Avenue and 111th Street, Edmonton, Alberta T6G 2H5, Canada
    Genome Med 1:22. 2009
  8. ncbi DNA databanks and consent: a suggested policy option involving an authorization model
    Timothy Caulfield
    Primary Care Research Unit, Department of Family and Community Medicine, Joint Centre for Bioethics, University of Toronto, Toronto, M4N 3M5, Canada
    BMC Med Ethics 4:E1. 2003
  9. ncbi Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries
    Nola M Ries
    Health Law Institute, Law Centre, University of Alberta, Edmonton, T6G 2H5, Canada
    BMC Med Ethics 11:4. 2010
  10. ncbi Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers
    Alethea Adair
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    BMC Med Ethics 10:6. 2009

Detail Information

Publications70

  1. ncbi The stem cell research environment: a patchwork of patchworks
    Timothy Caulfield
    Health Law Institute, Faculty of Law, University of Alberta, Edmonton, Canada
    Stem Cell Rev 5:82-8. 2009
    ..In one sense, the stem cell research context can be viewed as a living experiment occurring across the globe. The lessons to be gleaned from examining this field have great potential for broad-ranging general science policy application...
  2. ncbi DTC genetic testing: pendulum swings and policy paradoxes
    T Caulfield
    Health Law and Science Policy Group, University of Alberta, Edmonton, AB T6G 2H5, Canada
    Clin Genet 81:4-6. 2012
    ....
  3. ncbi The evolution of policy issues in stem cell research: an international survey
    Timothy Caulfield
    Health Law and Science Policy Group, University of Alberta, Edmonton, AB, Canada
    Stem Cell Rev 8:1037-42. 2012
    ..This survey provides useful insight into the perspectives of a sample of active researchers working in countries around the world as well as an opportunity to reflect on the likely direction of future stem cell policy debates...
  4. ncbi Science and the sources of hype
    T Caulfield
    Law Centre, University of Alberta, Edmonton, AB, Canada
    Public Health Genomics 15:209-17. 2012
    ..These numerous and interrelated factors create a 'hype pipeline' that will be difficult to counter without the utilization of a wide range of policy strategies...
  5. ncbi Open science versus commercialization: a modern research conflict?
    Timothy Caulfield
    Health Law and Science Policy Group, Law Centre, University of Alberta, Edmonton, T6G 2H5, Canada
    Genome Med 4:17. 2012
    ....
  6. ncbi Race and ancestry in biomedical research: exploring the challenges
    Timothy Caulfield
    Faculty of Law and School of Public Health Research, Health Law Institute, University of Alberta, 89 Ave and 111 St, T6G 2H5, Canada
    Genome Med 1:8. 2009
    ....
  7. ncbi Commercialization, patenting and genomics: researcher perspectives
    Cj Murdoch
    Health Law Institute, Law Centre, University of Alberta, 89th Avenue and 111th Street, Edmonton, Alberta T6G 2H5, Canada
    Genome Med 1:22. 2009
    ..Many researchers continue to raise concerns, particularly in relation to data withholding, thus emphasizing the need for a continued exploration of the complex issues associated with commercialization and patenting...
  8. ncbi DNA databanks and consent: a suggested policy option involving an authorization model
    Timothy Caulfield
    Primary Care Research Unit, Department of Family and Community Medicine, Joint Centre for Bioethics, University of Toronto, Toronto, M4N 3M5, Canada
    BMC Med Ethics 4:E1. 2003
    ..However, as all possible research questions that can be posed of the data are unknown, an unresolved ethical issue is the status of informed consent for future research uses of genetic material...
  9. ncbi Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries
    Nola M Ries
    Health Law Institute, Law Centre, University of Alberta, Edmonton, T6G 2H5, Canada
    BMC Med Ethics 11:4. 2010
    ....
  10. ncbi Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers
    Alethea Adair
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    BMC Med Ethics 10:6. 2009
    ..The objective of this study was to gain Canadian genetic health providers' perspectives on factors and criteria that influence and shape resource allocation decisions for publically funded predictive genetic testing in Canada...
  11. ncbi Trust, patents and public perceptions: the governance of controversial biotechnology research
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    Nat Biotechnol 24:1352-4. 2006
    ..The sustainability of many research endeavors, particularly in controversial areas, requires an understanding of public concerns. As such, governance strategies should be developed to sustain public trust...
  12. ncbi Obesity, legal duties, and the family physician
    Timothy Caulfield
    Faculty of Law and School of Public Health, Health Law Institute at the University of Alberta in Edmonton
    Can Fam Physician 53:1129-30, 1133-5. 2007
  13. ncbi Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate
    Timothy Caulfield
    University of Alberta, Edmonton, Alberta, Canada
    Am J Bioeth 7:51-61. 2007
    ..In this article, we provide a comprehensive and systematic legal analysis of the legislative process and parliamentary debates associated with the passage of this law...
  14. ncbi Introduction: genetic diversity and science communication
    T Caulfield
    Health Law and Policy, University of Alberta, Edmonton, Alberta, Canada
    Clin Genet 70:424-6. 2006
  15. ncbi Evidence and anecdotes: an analysis of human gene patenting controversies
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    Nat Biotechnol 24:1091-4. 2006
  16. ncbi Gene patents, health care policy and licensing schemes
    Timothy Caulfield
    Canada Research Chair in Health Law and Policy, Health Law Institute, University of Alberta, Canada T6G 2H5
    Trends Biotechnol 24:251-4. 2006
    ..At a minimum, policy makers need to be more realistic about the potential effects of international trade agreements on the development of biotechnology policies...
  17. ncbi Human dignity: a guide to policy making in the biotechnology era?
    Timothy Caulfield
    Faculty of Law, University of Alberta, Edmonton, Alberta T6G 2H5, Canada
    Nat Rev Genet 7:72-6. 2006
    ..In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies...
  18. ncbi Policy conflicts: gene patents and health care in Canada
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Canada
    Community Genet 8:223-7. 2005
    ..Although these issues have raised awareness about the possibility of reforming the patent system, Parliament has yet to consider any of the suggested reforms of the Canadian patent system and there are no formal proposals pending...
  19. ncbi Myriad and the mass media: the covering of a gene patent controversy
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Genet Med 9:850-5. 2007
    ..We explore how the print media in four jurisdictions framed the controversy surrounding Myriad Genetic's BRCA patents and consider the possible influence of media on public perceptions and policy reform...
  20. ncbi Research ethics recommendations for whole-genome research: consensus statement
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    PLoS Biol 6:e73. 2008
  21. ncbi Supported by science?: what canadian naturopaths advertise to the public
    Timothy Caulfield
    Health Law and Science Policy Group, University of Alberta, Edmonton, Canada
    Allergy Asthma Clin Immunol 7:14. 2011
    ..abstract:..
  22. ncbi Direct-to-consumer genetic testing: perceptions, problems, and policy responses
    Timothy Caulfield
    Faculty of Law and School of Public Health, Health Law and Science Policy Group, University of Alberta, Edmonton AB T6G 2H5, Alberta, Canada
    Annu Rev Med 63:23-33. 2012
    ....
  23. ncbi Science spin: iPS cell research in the news
    T Caulfield
    Faculty of Law and School of Public Health, Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Clin Pharmacol Ther 89:644-6. 2011
    ....
  24. ncbi Direct-to-consumer testing: if consumers are not anxious, why are policymakers?
    Timothy Caulfield
    Faculty of Law and School of Public Health, University of Alberta, Edmonton, Canada
    Hum Genet 130:23-5. 2011
    ..Indeed, it appears that genetic risk information has little impact on individual behavior or anxiety levels. Though more research is clearly needed, this type of research should inform the regulatory response to DTC services...
  25. ncbi Direct-to-consumer genetic testing: good, bad or benign?
    T Caulfield
    Faculty of Law, School of Public Health, University of Alberta, Edmonton, Alberta, Canada
    Clin Genet 77:101-5. 2010
    ..Intersectoral initiatives involving government regulators, professional bodies and industry are important to facilitate development of standards to govern this rapidly developing area of personalized genomic commerce...
  26. ncbi Patents, commercialization and the Canadian stem cell research community
    Timothy Caulfield
    Health Law Institute, Faculty of Law, University of Alberta, Edmonton, Alberta, Canada
    Regen Med 3:483-96. 2008
    ..We sought to assess the perceived impact of these factors on the stem cell research community in Canada...
  27. ncbi Biomedical research and the commercialization agenda: a review of main considerations for neuroscience
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Account Res 15:303-20. 2008
    ....
  28. ncbi Human dignity as a criterion for science policy
    Timothy Caulfield
    Faculty of Medicine and Dentistry, Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    PLoS Med 2:e244. 2005
  29. ncbi A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    BMC Complement Altern Med 5:12. 2005
    ..Homeopathy is one of the most widespread and most controversial forms of CAM. The purpose of this study was to compare the representation of homeopathic clinical trials published in traditional science and CAM journals...
  30. ncbi Human cloning laws, human dignity and the poverty of the policy making dialogue
    Timothy Caulfield
    Faculty of Law, Faculty of Medicine and Dentistry, University of Alberta, Canada
    BMC Med Ethics 4:E3. 2003
    ..The notion of "human dignity" is commonly used to justify cloning laws. The basis for this justification is that reproductive human cloning necessarily infringes notions of human dignity...
  31. ncbi Scientific freedom and research cloning: can a ban be justified?
    Timothy Caulfield
    Faculty of Law and Faculty of Medicine and Dentistry, Health Law Institute, University of Alberta, Edmonton, Canada T6G 2H5
    Lancet 364:124-6. 2004
  32. ncbi Creating needs? A review of survey data and concerns relevant to the commercialization of genetic testing
    T Caulfield
    Faculty of Law, Faculty of Medicine and Dentistry, Health Law Institute, University of Alberta, 461 Law Centre, Edmonton, Alberta, T6G 2H5 Canada
    Community Genet 4:68-76. 2001
    ..As such, the concerns associated warrant careful consideration...
  33. ncbi Genetic technologies, health care policy and the patent bargain
    T A Caulfield
    Faculty of Law, University of Alberta, Edmonton, Alberta, Canada
    Clin Genet 63:15-8. 2003
    ..Creative and bold patent reform initiatives are necessary to ensure that society will, to the highest degree possible, reap the health care benefits of the genetic revolution...
  34. ncbi Physicians' liability and drug formulary restrictions
    Timothy Caulfield
    Faculty of Law, University of Alberta, Edmonton
    CMAJ 166:458-60. 2002
  35. ncbi Variations and voids: the regulation of human cloning around the world
    Shaun D Pattinson
    Health Law Institute, Faculty of Law and Faculty of Medicine and Dentistry, University of Alberta, Canada
    BMC Med Ethics 5:E9. 2004
    ..It highlights the challenges associated with the regulation of a controversial and rapidly evolving area of science and sheds light on a regulatory framework that can accommodate this reality...
  36. ncbi Patenting human genetic material: refocusing the debate
    T Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alberta, T6G 2H5, Canada
    Nat Rev Genet 1:227-31. 2000
    ..Here we discuss some of these concerns, the patent authorities' response to them, and ways in which to address these issues and to move the debate forward using current legal structures...
  37. ncbi Law and policy in the era of reproductive genetics
    T Caulfield
    Faculty of Law, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta T6G 2H5, Canada
    J Med Ethics 30:414-7. 2004
    ..Such a policy must attend to the evolving scientific developments and ethical considerations. We outline a proposal for effective, responsive, and coherent oversight of new reproductive genetic technologies...
  38. ncbi The law, adolescents, and the APOE epsilon 4 genotype: a view from Canada
    T A Caulfield
    Stanford University Program in Genomics, Ethics, and Society, Palo Alto, CA 94304, USA
    Genet Test 3:107-13. 1999
    ..The physician should not be able to inform the parents of the test results without the adolescent's consent, nor should the adolescent be forced to disclose those results...
  39. ncbi The commercialisation of medical and scientific reporting
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    PLoS Med 1:e38. 2004
  40. ncbi Regulating the genetic revolution
    T Caulfield
    Faculties of Law and Medicine, Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Mol Med Today 5:198-200. 1999
    ..Although there are certainly many valid social and ethical concerns worthy of a regulatory response, legislating genetic policy will not be easy...
  41. ncbi Biotechnology and the popular press: hype and the selling of science
    Timothy Caulfield
    Health Law Institute, 461 Law Centre, University of Alberta, Edmonton, Alberta, T6G 2H5 Canada
    Trends Biotechnol 22:337-9. 2004
    ..As such, there are reasons to believe that the hyping of research results might be part of a more systemic problem associated with the increasingly commercial nature of the research environment...
  42. ncbi The commercialization of human genetics: profits and problems
    T Caulfield
    Health Law Institute, Faculty of Law, University of Alberta, Edmonton, Canada
    Mol Med Today 4:148-50. 1998
    ..This article explores these costs and examines whether the commercialization of academic research is compromising academic freedom, progress in clinical research, and our attitudes to normal good health...
  43. ncbi Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: integrating science, legal duties and ethical mandates
    T Caulfield
    Health Law Institute, Faculty of Law, University of Alberta, Edmonton
    CMAJ 157:1389-92. 1997
    ..g., through a series of public health announcements), it should provide, for people who wish to know, the opportunity to find out whether they were given CJD-associated products...
  44. ncbi Tissue banking, patient rights, and confidentiality: tensions in law and policy
    T Caulfield
    Canada Research Chair in Health Law and Policy, Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Med Law 23:39-49. 2004
    ..Nevertheless, conflicts between existing common law, research ethics policy and new health information legislation illustrate profound policy dilemmas created by research involving storage and use of tissue and genetic material...
  45. ncbi Clones, controversy, and criminal law: a comment on the proposal for legislation governing assisted human reproduction
    T Caulfield
    Faculty of Law and Faculty of Medicine and Dentistry; Research Director, Health Law Institute, University of Alberta, Canada
    Alta Law Rev 39:335-45. 2001
    ..The author suggests a more flexible and responsive system of moratoriums and licenses that would enable review and adjustment to the realities of emerging reproductive technologies is a better approach...
  46. ncbi Media portrayal of herbal remedies versus pharmaceutical clinical trials: impacts on decision
    T Bubela
    Department of Marketing, Business Economics and Law, School of Business, Business Building, University of Alberta, Edmonton, Alberta
    Med Law 26:363-73. 2007
    ..The next step in the research is to determine whether these reporting dynamics in describing CAM clinical trials differ from those of reporting on pharmaceutical clinical trials...
  47. ncbi Xenotransplantation: consent, public health and charter issues
    T A Caulfield
    Faculty of Law, University of Alberta, Canada
    Med Law Int 5:81-99. 2001
    ..Effective surveillance programs will require novel approaches to consent and the enactment of specific public health laws...
  48. ncbi Willingness to pay for genetic testing: a study of attitudes in a Canadian population
    N M Ries
    Health Law Institute, University of Alberta, Edmonton, Alta, Canada
    Public Health Genomics 13:292-300. 2010
    ..The goal was to explore attitudes and interest regarding different types of genetic tests...
  49. ncbi Legal foundations for a national public health agency in Canada
    Nola M Ries
    Health Law Institute, Law Centre, University of Alberta, Edmonton
    Can J Public Health 96:281-3. 2005
    ....
  50. ncbi The regulation of science and the Charter of Rights: would a ban on non-reproductive human cloning unjustifiably violate freedom of expression?
    Barbara Billingsley
    University of Alberta, Canada
    Queens Law J 29:647-79. 2004
    ..As there has been no Charter litigation to date on whether scientific research is a form of expression, the authors introduce a new way of looking at the legality of the regulation of new reproductive technologies...
  51. ncbi Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment
    Timothy Caulfield
    Faculty of Law, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
    Health Law Rev 13:58-61. 2005
  52. ncbi Genetics and market forces
    Timothy Caulfield
    Nat Rev Genet 3:734. 2002
  53. ncbi Bill C-13 The Assisted Human Reproduction Act: examining the arguments against a regulatory approach
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Health Law Rev 11:20-5. 2002
  54. ncbi Politics, prohibitions and the lost public perspective: a comment on Bill C-56: the Assisted Human Reproduction Act
    Timothy Caulfield
    Faculty of Law, University of Alberta, Canada
    Alta Law Rev 40:451-63. 2002
  55. ncbi DNA databanks, public opinion and the law
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alta
    Clin Invest Med 25:252-6. 2002
  56. ncbi Research ethics and the role of the professional bodies: a view from Canada
    Timothy Caulfield
    Canada Research Chair in Health Law and Policy, Health Law Institute at the University of Alberta, Canada
    J Law Med Ethics 32:365-8. 2004
  57. ncbi Stem cells, politics and the progress paradigm
    Suzanne DeBow
    Health Law Institute, University of Albert, Edmonton, Alberta, Canada
    Health Law Rev 15:50-2. 2006
  58. ncbi Commentary: an independent voice?: conflicts of interest and research on ethical, legal and social issues
    Timothy Caulfield
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Health Law Rev 13:114-6. 2005
  59. ncbi Informed consent in embryonic stem cell research: are we following basic principles?
    Timothy Caulfield
    Faculty of Law and the School of Public Health, University of Alberta, Edmonton, Alta
    CMAJ 176:1722-5. 2007
  60. ncbi Somatic cell nuclear transfer--how science outpaces the law
    Timothy Caulfield
    Nat Biotechnol 21:969-70. 2003
  61. ncbi Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research
    Timothy Caulfield
    University of Alberta, Canada
    Sask Law Rev 66:629-45. 2003
  62. ncbi Medicine. The future of personal genomics
    Amy L McGuire
    Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX 77030, USA
    Science 317:1687. 2007
  63. ncbi Research ethics and the challenge of whole-genome sequencing
    Amy L McGuire
    Amy L McGuire is at the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas 77030, USA
    Nat Rev Genet 9:152-6. 2008
    ..Although the issues are not new, we discuss their implications for personal genomics and provide recommendations for appropriate management in the context of research involving individual whole-genome sequencing...
  64. ncbi Media portrayal of conflicts of interest in herbal remedy clinical trials
    Megan Koper
    Health Law Institute, University of Alberta, Edmonton, Alberta, Canada
    Health Law Rev 15:9-11. 2006
  65. ncbi An investigation of embryo donation, informed consent, and research oversight in Canadian human embryonic stem cell research
    Erin Nelson
    Health Law Institute, Faculty of Law, University of Alberta, Edmonton AB
    J Obstet Gynaecol Can 29:997-1002. 2007
    ....
  66. ncbi Conflicts of interest in clinical research: addressing the issue of physician remuneration
    Timothy Caulfield
    Faculty of Law, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    J Law Med Ethics 30:305-8. 2002
  67. ncbi Gene banks and blanket consent
    Timothy Caulfield
    Nat Rev Genet 3:577. 2002
  68. ncbi Ethics watch. Public perceptions and regulatory policy
    Timothy Caulfield
    Nat Rev Genet 3:902. 2002
  69. ncbi Stem cell research ethics: consensus statement on emerging issues
    Timothy Caulfield
    Health Law Institute, Faculty of Law, School of Public Health, University of Alberta, Edmonton AB
    J Obstet Gynaecol Can 29:843-8. 2007
    ....
  70. ncbi Human cloning a decade after Dolly
    Timothy Caulfield
    CMAJ 176:613. 2007